Globus Medical Q4 2022 Earnings Report
Key Takeaways
Globus Medical reported a record-setting fourth quarter in 2022, achieving record total sales, U.S. Spine sales, and Enabling Technologies sales. Worldwide net sales increased by 9.8% to $274.5 million, with GAAP net income rising by 231.4% to $50.1 million. The company's diluted EPS was $0.49, and non-GAAP diluted EPS was $0.59.
Worldwide net sales increased by 9.8% to $274.5 million.
GAAP net income increased by 231.4% to $50.1 million.
Diluted EPS was $0.49 and non-GAAP diluted EPS was $0.59.
Non-GAAP adjusted EBITDA was $90.2 million, representing 32.8% of net sales.
Globus Medical
Globus Medical
Globus Medical Revenue by Segment
Globus Medical Revenue by Geographic Location
Forward Guidance
The Company announced full year stand-alone 2023 guidance with expected net sales of $1.1 billion and non-GAAP diluted earnings per share of $2.30.
Positive Outlook
- Expected net sales of $1.1 billion.
- Non-GAAP diluted earnings per share of $2.30.
Revenue & Expenses
Visualization of income flow from segment revenue to net income